Registration | Bimzelx

The contents of this website are intended for US healthcare professionals only.

Indication

BIMZELX^® (bimekizumab-bkzx) is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Create A New Account

Account Information

Please complete the information below to create an account. If you already have an account and would like to log in, click here.
* Indicates a required field.

Profession*

Specialty*

First Name*

Last Name*

Institution*

NPI*

Email*

Phone Number*

Address 1*

Address 2

Address 3

City*

State*

Zip*

Create Login

Username*

Password*

Confirm Password*

PRIVACY POLICY TERMS OF USE

This site is intended for U.S. healthcare professionals.
BIMZELX^® is a registered trademark of the UCB Group of Companies. All other trademarks and registered trademarks are the property of their respective holders.
�2024 UCB, Inc., Smyrna, GA 30080
All rights reserved.
US-P-BK-PSO-2300017

PRIVACY POLICY TERMS OF USE

This site is intended for U.S. healthcare professionals.
BIMZELX^® is a registered trademark of the UCB Group of Companies. All other trademarks and registered trademarks are the property of their respective holders.
�2024 UCB, Inc., Smyrna, GA 30080
All rights reserved.
US-P-BK-PSO-2300017